High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
Breast cancer is the most common malignancy affecting women, but the heterogeneity of the condition is a significant obstacle to effective treatment. Triple negative breast cancers (TNBCs) do not express HER2 or the receptors for estrogen or progesterone, and so often have a poor prognosis. Tumor-in...
Main Authors: | Joe Yeong, Jeffrey Chun Tatt Lim, Bernett Lee, Huihua Li, Noel Chia, Clara Chong Hui Ong, Weng Kit Lye, Thomas Choudary Putti, Rebecca Dent, Elaine Lim, Aye Aye Thike, Puay Hoon Tan, Jabed Iqbal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01209/full |
Similar Items
-
Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
by: Runyi Adeline Lam, et al.
Published: (2021-07-01) -
Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients
by: Laurent Gole, et al.
Published: (2020-05-01) -
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
by: Joe Yeong, et al.
Published: (2019-02-01) -
Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers
by: Muhammad Zubair, et al.
Published: (2017-06-01) -
Successful triple immunoenzymatic method employing primary antibodies from same species and same immunoglobulin subclass
by: T. A. Osman, et al.
Published: (2013-09-01)